Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Berkmortel, F van de
OPTImaL, NCT06476119: Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes	Not yet recruiting	N/A	490	Europe	Adjuvant chemotherapy, according to local/ national guidelines, No adjuvant chemotherapy	The Netherlands Cancer Institute, Maarten van de Weijden Foundation, AVL Foundation	Breast Cancer Stage I, Triple Negative Breast Cancer (TNBC)	09/32	09/34
Peters, Frank PJ
CRITICS-II, NCT02931890 / 2015-004627-31: Multicentric Randomised Trial for Resectable Gastric Cancer	Active, not recruiting	2	207	Europe	Docetaxel, Taxotere, Oxaliplatin, Eloxatin, Capecitabine, Xeloda, gastrectomy, radiotherapy of gastric cancer, Paclitaxel, Carboplatin	The Netherlands Cancer Institute	Gastric Cancer	04/25	03/29